Machine learning based readmission and mortality prediction in heart failure patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
31 10 2023
31 10 2023
Historique:
received:
05
03
2023
accepted:
25
10
2023
medline:
2
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
epublish
Résumé
This study intends to predict in-hospital and 6-month mortality, as well as 30-day and 90-day hospital readmission, using Machine Learning (ML) approach via conventional features. A total of 737 patients remained after applying the exclusion criteria to 1101 heart failure patients. Thirty-four conventional features were collected for each patient. First, the data were divided into train and test cohorts with a 70-30% ratio. Then train data were normalized using the Z-score method, and its mean and standard deviation were applied to the test data. Subsequently, Boruta, RFE, and MRMR feature selection methods were utilized to select more important features in the training set. In the next step, eight ML approaches were used for modeling. Next, hyperparameters were optimized using tenfold cross-validation and grid search in the train dataset. All model development steps (normalization, feature selection, and hyperparameter optimization) were performed on a train set without touching the hold-out test set. Then, bootstrapping was done 1000 times on the hold-out test data. Finally, the obtained results were evaluated using four metrics: area under the ROC curve (AUC), accuracy (ACC), specificity (SPE), and sensitivity (SEN). The RFE-LR (AUC: 0.91, ACC: 0.84, SPE: 0.84, SEN: 0.83) and Boruta-LR (AUC: 0.90, ACC: 0.85, SPE: 0.85, SEN: 0.83) models generated the best results in terms of in-hospital mortality. In terms of 30-day rehospitalization, Boruta-SVM (AUC: 0.73, ACC: 0.81, SPE: 0.85, SEN: 0.50) and MRMR-LR (AUC: 0.71, ACC: 0.68, SPE: 0.69, SEN: 0.63) models performed the best. The best model for 3-month rehospitalization was MRMR-KNN (AUC: 0.60, ACC: 0.63, SPE: 0.66, SEN: 0.53) and regarding 6-month mortality, the MRMR-LR (AUC: 0.61, ACC: 0.63, SPE: 0.44, SEN: 0.66) and MRMR-NB (AUC: 0.59, ACC: 0.61, SPE: 0.48, SEN: 0.63) models outperformed the others. Reliable models were developed in 30-day rehospitalization and in-hospital mortality using conventional features and ML techniques. Such models can effectively personalize treatment, decision-making, and wiser budget allocation. Obtained results in 3-month rehospitalization and 6-month mortality endpoints were not astonishing and further experiments with additional information are needed to fetch promising results in these endpoints.
Identifiants
pubmed: 37907666
doi: 10.1038/s41598-023-45925-3
pii: 10.1038/s41598-023-45925-3
pmc: PMC10618467
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18671Informations de copyright
© 2023. The Author(s).
Références
PLoS One. 2020 Apr 15;15(4):e0221606
pubmed: 32294087
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
BMJ Open. 2021 Jul 23;11(7):e044779
pubmed: 34301649
Ther Clin Risk Manag. 2021 Dec 07;17:1307-1320
pubmed: 34908840
J Biomed Inform. 2015 Aug;56:229-38
pubmed: 26044081
Med Care. 2016 Apr;54(4):365-72
pubmed: 26978568
Nat Rev Dis Primers. 2020 Mar 5;6(1):16
pubmed: 32139695
J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):15-20
pubmed: 28634519
Int J Cardiol. 2019 Dec 15;297:83-90
pubmed: 31615650
Am Heart J. 2001 Oct;142(4):E7
pubmed: 11579371
J Transl Med. 2022 Mar 18;20(1):136
pubmed: 35303896
World J Nephrol. 2015 Feb 6;4(1):57-73
pubmed: 25664247
Pharmacoeconomics. 2020 Nov;38(11):1219-1236
pubmed: 32812149
PLoS One. 2019 Jul 8;14(7):e0219302
pubmed: 31283783
BMC Med Inform Decis Mak. 2018 Jun 22;18(1):44
pubmed: 29929496
Circ Heart Fail. 2021 Apr;14(4):e008335
pubmed: 33866827
Circulation. 1998 Mar 17;97(10):958-64
pubmed: 9529263
Health Serv Res Manag Epidemiol. 2017 Apr 18;4:2333392817701050
pubmed: 28462286
ESC Heart Fail. 2019 Apr;6(2):428-435
pubmed: 30810291
Trends Cardiovasc Med. 2020 Feb;30(2):104-112
pubmed: 31006522
J Card Fail. 2016 Nov;22(11):875-883
pubmed: 27133201
JAMA. 2007 Mar 14;297(10):1063-72
pubmed: 17356027
Clin Cardiol. 2021 Feb;44(2):230-237
pubmed: 33355945
Heart Lung. 2017 Sep - Oct;46(5):357-362
pubmed: 28801110
Echocardiography. 2019 Feb;36(2):213-218
pubmed: 30515886
Artif Intell Med. 2015 Oct;65(2):89-96
pubmed: 26363683
Clin Cardiol. 2022 Apr;45(4):370-378
pubmed: 35077583
Eur J Heart Fail. 2018 Feb;20(2):304-314
pubmed: 29082629
ESC Heart Fail. 2021 Feb;8(1):106-115
pubmed: 33205591
Sci Rep. 2019 Jun 26;9(1):9277
pubmed: 31243311
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Int J Cardiol. 2019 Mar 1;278:186-191
pubmed: 30579719
ESC Heart Fail. 2021 Aug;8(4):3026-3036
pubmed: 34085775
J Cardiovasc Thorac Res. 2022;14(1):11-17
pubmed: 35620751